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A B S T R A C T
First presented by Brugada and Brugada in 1992, Brugada Syndrome (BrS) is a primary electrical disease of the heart
that causes sudden cardiac death or life-threatening ventricular arrhythmias. This disease is hereditary autosomic domi-
nant transmitted and genetically determined. The syndrome has been linked to mutations in SCN5A, the gene encoding for
the a-subunit of the sodium channel. Electrocardiogram (ECG) abnormalities indicating Brugada syndrome, include re-
polarization and depolarization abnormalities in the absence of identifiable structural cardiac abnormalities or other con-
ditions or agents known to lead to ST-segment elevation in the right precordial leads (V1-V3). Intravenous administration
of sodium channel blocking drugs may modify the ECG pattern. Ajmaline, flecainide, procainamide and propafenone
exaggerate the ST-segment elevation or unmask it when it is initially absent. An implantable cardioverter-defibrillator
(ICD) is the only proven effective device treatment for the disease. Although BrS is primary electrical disease, some authors
have suggested the presence of morphological and functional abnormalities mainly located in the right ventricle (RV),
notably in the outflow tract (RVOT). In this short report we will present a young male, with predisposition and positive
family history of sudden cardiac death, with complete diagnostic procedure including propafenon testing unmasking Bru-
gada syndrome. An echosonography revealed dilated apical right ventricle, suggesting BrS is not only electrical disorder,
but may include morphofunctional abnormalities, described in previous reports. In addition, we reviewed the possible
connection between Brugada syndrome and morphological abnormalities in RV.
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ventricular cardiomyopathy, ST-segment elevation in the right precordial leads
Introduction
Since its initial discovery in 1992, the Brugada syn-
drome (BrS) has instigated many studies, due to high
risk of sudden death, especially in the young and other-
wise healthy people1. The Brugada syndrome is character-
ized by an ST segment elevation in the right precordial
leads and a high incidence of sudden death in patients
with structurally normal heart2. There are three type’s
of Brugada ECG patterns of which only type 1 is diagnos-
tic of the Brugada syndrome3. Type one is characterized
by a coved ST-segment elevation =2 mm (0.2 mV) fol-
lowed by a negative T wave in more than one right pre-
cordial leads (V1-V3) in the presence or absence of so-
dium channel-blocking agent. Type two is characterized
by a saddleback ST-segment elevation with a high takeoff
ST elevation of =2 mm or through displaying =1 mm ST
elevation, and either positive or biphasic T wave. Type
three has either a saddleback or coved appearance with
an ST-segment elevation of <1 mm2-3.
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Inheritance of Brugada syndrome occurs via an auto-
somal dominant mode of transmission. Gene linked to
Brugada syndrome is SCN5A, that encodes for the alpha
subunit of the cardiac sodium channel gene2,4. For many
years BrS has been considered a purely electrical disease,
although recently, some authors have suggested the pres-
ence of morphological abnormalities leading to functio-
nal abnormalities in patients with BrS, predominately lo-
cated in the right ventricle (RV) and especially in the
outflow tract (RVOT)5,6. The benefit of cardiac magnetic
resonance imaging (CMRI) was also examined in some
studies, concluding as well, that CMRI detects a high
prevalence of mild structural changes of the RV in pa-
tients with BrS, suggesting structural patophysiology in
BrS7. Morphofunctional abnormalities such as dilatation
and dysfunction of RV on echocardiography were also
reported8,9, as well as atrophy or fatty replacement of the
RV in 20% of patients with BrS by Papavassiliu et al10.
Right ventricular morphological and functional ab-
normalities, such as global dilatation, aneurysm and wall
motion abnormalities, due to fat replacement of myocar-
dial tissue, are characteristically displayed in arrhytmo-
genic right ventricular cardiomyopathy (ARVC)11.
In contrast to BrS, ventricular arrhythmias in ARVC
are most commonly monomorphic VTs, often precipitat-
ed by catecholamines, or exercise, whereas in BrS ar-
rhythmias and typical ECG pattern are enhanced by
vagotonic agents or beta adrenergic blockers, and ven-
tricular arrhythmias are most often polymorphic and
commonly occur at sleep or rest11,12. BrS and ARVC are
two distinct clinical entities, regarding both, clinical pre-
sentation and genetic predisposition13. Nevertheless, new
findings suggest the presence of morphological abnorma-
lities in the patients with BrS5–9.
Case report
A 48-year old man was administrated to our clinic for
regular examination. His medical history revealed only
hyperlipidemia treated by dietary measures, while no
history of tobacco, drugs or alcohol abuse was present.
He did not have any specific symptoms and tolerated well
moderate physical activities. When asked about sudden
cardiac death in young relatives, he reported that one
brother, in the age of 42, and other brother in the age of
31 died suddenly, and the third brother, living abroad,
has an implanted cardioverter defibrillator (ICD), but he
didn't know why. On examination, his vital signs were
normal. His 12-lead ECG pattern showed an rsR’ pattern
in V1 and rSr’ pattern in V2, consistent with incomplete
right bundle branch block with QRSD of 113 ms, and left
anterior hemiblock (LAH) (Figure 1). Interestingly, dur-
ing monitoring in coronary care unit his ECG spontane-
ously showed intermittent ST segment elevation in leads
V2-V3 characteristic for patients with BrS2,13.
A transthoracic echocardiogram was also performed,
which demonstrated a structurally normal left ventricle
with normal systolic and diastolic function. One patho-
logical feature that was found was an aneurismatic dila-
tation of an apical part of right ventricle (Figure 4). He
had mild aortic regurgitation, and mild pulmonary re-
gurgitation.
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Fig. 1. On admittion ECG pattern revealed rsR’ pattern in V1
and rSr’ pattern in V2, consistent with incomplete right bandle
branch block and left anterior hemiblock (LAH).
Fig. 2. After 70 mg of Propafenon, prolongation of QRS distance
was noted from 113 to 130 ms, and elevation of an ST segment
from V1 to V3 leades.
Fig. 3. After additional 140 mg of Propafenone further prolonga-
tion of QRS distance to 149 ms was noted with significantly high-
er ST segment elevation from V1-V3 leads.
Patient was submitted to treadmill test by Bruce pro-
tocol, which he completed by achieving targeted heart
rate (158/min) after 13 minutes of testing (fifth stage,
250 W). During test he had no chest pain, his ECG pat-
tern showed no arrhythmias or ST segment changes.
In addition, cardiac catheterization revealed no signifi-
cant obstructive coronary artery disease; visual estima-
tion showed only luminal irregularities of circumflex coro-
nary artery, nonsignificant stenosis of mid right coronary
artery (40%) of the ostium of the ramus intermedius
(50%).
Cardiac magnetic resonance imaging (CMRI) revealed
normal contractile function of the heart, with slightly
marked component of transversal diameter of both left
and right atrium, suggesting discrete enlargement.
During monitoring in coronary care unit Propafenon
test was performed. We started by administrating Propa-
fenon at dosage of 2 mg/kg/TT. After administration of
70 mg of Propafenon, prolongation of QRS distance was
noted from 113 to 130 ms, and elevation of an ST seg-
ment from V1 to V3 leads (Figure 2). Further, we addi-
tionally administrated 140 mg of Propafenone, which
was followed by further prolongation of QRS distance to
149 ms (Figure 3) and significantly higher ST segment
elevation from V1-V3 leads. After 5 minutes of monitor-
ing, regression of QRS distance was recorded with nor-
malization of ST segment on leads V2-V3. This was con-
sistent with positive Propafenon testing which confir-
med diagnosis of Brugada syndrome, by unmasking ECG
pattern to type I. On 21 July 2010 he was implanted
cardioverter defibrillator (ICD). The ICD was tested dur-
ing implantation and functioned properly. His sons were
advised to undergo screening.
Discussion
The prevalence of the Brugada syndrome in the gene-
ral population is difficult to determine as persons with
Brugada syndrome usually do not have symptoms and
their first presentation can be sudden death14,15.
It is sometimes difficult to diagnose and make risk
stratification for patients with BrS.
On the other hand, a sudden cardiac death due to
physical exercise in young athletes in Croatia suffered
of arrhythmogenic right ventricular dysplasia reached
0.07/100 000 yearly, in all young athletes suffered of
heart diseases reached 0.19/100 000 yearly, and in the
total male population aged 15–40 engaged in sports and
recreational physical exercise: 0.71/100 000 yearly16–20.
In our case, a patient had the electrocardiographic
anomalies when we administrated Propafenone. Drugs
usually used to unmask BrS, are sodium channel block-
ing drugs Ajmaline, Flecainide, Procainamide, Pilsicai-
nide and Propafenone2,20,21.
Positive Propafenon test and positive family history of
sudden cardiac death of two brothers, were sufficient to
implant profilactically ICD. The Report of the Second
Consensus Conference on Brugada Syndrome, published
in 2005, stated that for asymptomatic patients with family
history of sudden cardiac death suspected to be due to
BrS, implantation of ICD is a class IIa recommendation2.
Finding of an aneurismatic dilatation of an apical part
of right ventricle on echocardiography supports latest con-
cept that relevant percentage of BrS patients have RV
morphofunctional abnormalities. Despite the original con-
cept that BrS exclude structural abnormalities of the
heart it is clear that further studies on this subject are
needed.
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Fig. 4. A transthoracic echocardiogram showed an aneurismatic
dilatation of an apical part of right ventricle.
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BRUGADA SYNDROM I MORFOLO[KE I FUNKCIONALNE ABNORMALNOSTI DESNOG
VENTRIKULA U MLADOG MU[KARCA SA OBITELJSKOM ANAMNEZOM NAGLE SR^ANE SMRTI
S A @ E T A K
Prvi puta objavljen od strane autora Brugada i Brugada 1992 godine, Brugada Sindrom (BrS) je primarno elektri~ni
poreme}aj srca, koji mo`e uzrokovati naglu sr~anu smrt ili maligne poreme}aje sr~anog ritma. Bolest je nasljedna, a
prenosi se autosomno dominantno i genetski je odre|ena. Iako je velik broj gena analiziran, sindrom je sa sigurno{}u
povezan sa mutacijama u genu SCN5A, gen koji kodira a-podjedinicu natrijevih kanala. ECG promjene koje indiciraju
Brugada sindrom, ukjlju~uju repolarizacijske i depolarizacijske promjene u odsutnosti strukturne bolesti srca ili drugih
stanja ili lijekova za koje je poznato da mogu dovesti do elevacije ST-segmenta u desnim prekordijalnim odvodima (V1-V3).
Intravenska primjena blokatora natrijevih kanala, mogu izmjeniti izgleg EKG-a. Ajmalin, flekainid, prokainamid i pro-
pafenom poja~avaju elevaciju ST-segmenta ili ju demaskiraju ako je inicijalno skrivena. Implantibilni kardioverter defi-
brilator (ICD) jedino je dokazano u~inkovito lije~enje ove bolesti. Iako je BrS primarno elektri~ka bolest, neki su autori
predlo`ili mogu}nost prisutstva morfolo{kih i funkcionalnih abnormalnosti uglavnom smje{tenih u desnom ventrikulu
(DV), naj~e{}e u izgonskom traktu DV. U ovom kratkom ~lanku prikazat }emo slu~aj mladog mu{karca, sa predispo-
zicijom i pozitivnom obiteljskom anamnezom nagle sr~ane smrti. Bolesniku je u~injena kompletna dijagnosti~ka obrada,
te je u~injen Propafenonski test, koji je bio pozitivan, te otkrio EKG promjene karakteristi~ne za BrS. Ehokardiografski
pregled je pokazao dilatiran apikalni segment DV, {to je sugeriralo da BrS nije samo elektri~ki poreme}aj srca, nego
mo`da uklju~uje i morfofunkcionalne abnormalnosti, {to je i opisivano u literaturi. U kona~nici, razmotrili smo mogu-
}nost povezanosti Brugada sindroma i morfolo{kih abnormalnosti DV.
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